europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

EuropaBio invited healthcare biotech SMEs to learn about EU Policy Priorities

07/06/2021
NEWS RELEASE
Brussels, 3 June 2021

EuropaBio organised an online info session for SMEs active within the healthcare biotechnology sector to learn about the key EU policies and their possible impact on their current business strategies. This was the second event organised under the EuropaBio SME Platform initiative.

EuropaBio’s Healthcare Biotechnology team Bernard Grimm, Violeta Georgieva and Darren Kinsella gave an overview of some key ongoing initiatives affecting healthcare biotechnology in the EU. Our experts reviewed the ongoing revision of the Orphan Medicinal Products Regulation and its impact on SMEs involved in researching new therapies for rare diseases, the EU IP Action Plan and the importance of intellectual property for small businesses, and the multi-layered Pharmaceutical Strategy for Europe. Participants had the chance to learn about the recently launched EuropaBio’s Biopharmaceutical Strategy Group, a forum for members, where some of the key initiatives within the EU Pharmaceutical legislation revision will be addressed.

The event was moderated by Darren Kinsella, Healthcare Biotechnology Manager at EuropaBio.

Please click on the links to access the event’s slides and the recording.

The next online webinar on funding for SMEs will take place June 17, 2021. Please register here.

About the EuropaBio SME Platform

The SME platform is a community of SMEs across all sectors in Europe, supported through regular online meetings around EU-level topics that impact commercial biotechnology and represented to EU stakeholders.

EuropaBio invited healthcare biotech SMEs to learn about EU Policy Priorities


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

23/03/2023

Unlocking the Potential of Biotechnology Innovation for Patients


Read more
16/03/2023

Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future


Read more
07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders


Read more
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies